HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitation of human thymus/leukemia-associated antigen by radioimmunoassay in different forms of leukemia.

Abstract
Using a radioimmunoassay, increased levels of a human thymus/leukemia-associated antigen (HThy-L) have been detected in leukemic cells and plasma from most patients with E-rosette-positive acute lymphoblastic leukemia (ALL) and a number of patients with E-rosette-negative ALL, acute myeloblastic leukemia (AML), acute monomyelocytic leukemia (AMML), and acute undifferentiated leukemia (AVL). Low levels of HThy-L have been demonstrated in white cells from patients with chronic myelocytic leukemia (stable phase) and in mononuclear cells from patients with chronic lymphatic leukemia. The relationship between HThy-L and differentiation of hematopoietic cells is discussed.
AuthorsB E Chechik, J Jason, A Shore, M Baker, H M Dosch, E W Gelfand
JournalBlood (Blood) Vol. 54 Issue 6 Pg. 1400-6 (Dec 1979) ISSN: 0006-4971 [Print] United States
PMID292458 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antigens, Neoplasm
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Leukemia (immunology)
  • Leukemia, Lymphoid (immunology)
  • Leukemia, Myeloid (immunology)
  • Leukemia, Myeloid, Acute (immunology)
  • Male
  • Middle Aged
  • Radioimmunoassay
  • Rosette Formation
  • Thymus Gland (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: